BioSpace News Archive

DURECT Corporation announced financial results for the three months and year ended December 31, 2021 and provided a corporate update.

Aytu BioPharma, Inc. announced the closing of its previously announced underwritten offering of 3,030,000 shares of its common stock, pre-funded warrants to purchase up to 3,030,000 shares of its common stock, and common warrants to purchase up to 6,666,000 shares of its common stock resulting in gross proceeds of $7.6 million, assuming none of the accompanying common warrants issued in the Offering are exercised.

Southwest Research Institute will collaborate with University of Michigan to use additive manufacturing and machine learning to create an advanced burner that will eliminate 99.5% of the methane encountered during oil production.

Rakuten Medical, Inc. has elected to discontinue use of the name “Illuminox,” and to start using a new, evolved name “Alluminox™" for our proprietary, anti-cancer, photoimmunotherapy technology platform, which is comprised of drug, medical device, and other related technologies.

Miniaturization and standardization have been driving the rising demand for deep-drawn metal components in the medical industry.